Illumina, Inc. (ILMN)
NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EST
Dopo ore:
| Chiusura precedente | 214,26 |
| Aperto | 211,57 |
| Denaro | 0,00 x 1100 |
| Lettera | 0,00 x 800 |
| Min-Max giorno | 206,41 - 212,72 |
| Intervallo di 52 settimane | 173,45 - 371,16 |
| Volume | |
| Media Volume | 1.183.608 |
| Capitalizzazione | 32,829B |
| Beta (5 anni mensile) | 1,13 |
| Rapporto PE (ttm) | 47,00 |
| EPS (ttm) | 4,44 |
| Prossima data utili | 07 feb 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 243,50 |
- GlobeNewswire
Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)
- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business Combination Agreement with DYNS - - DYNS announces effectiveness of registration statement on Form S-4 - - Meeting of DYNS stockholders to approve proposed business combination scheduled for Tuesday, June 7, 2022 at 10:00 a.m. ET - SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Senti Bioscien
© 2023 Yahoo. Tutti i diritti riservati.
